Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
暂无分享,去创建一个
T. Rebbeck | S. Gruber | E. Iversen | J. Garber | C. Isaacs | D. Finkelstein | R. Sutphen | P. Marcom | G. Ursin | S. Domchek | B. Arun | J. Schildkraut | P. Moorman | C. Griffin | K. Visvanathan | Eunjung Lee | L. Susswein | Frances F Wang | Jennifer Brzosowicz | J. Marks | Kathleen Cuningham Consortium for Research into Familial Br Cancer | Jennifer P. Brzosowicz
[1] M. Urioste,et al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers , 2009, Breast Cancer Research and Treatment.
[2] P. Goodwin,et al. Prognosis of BRCA-associated breast cancer: a summary of evidence , 2009, Breast Cancer Research and Treatment.
[3] B. Henderson,et al. Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study , 2008, Cancer Epidemiology Biomarkers & Prevention.
[4] Christopher I Amos,et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] A. Tutt,et al. Triple negative tumours: a critical review , 2007, Histopathology.
[6] Giovanni Parmigiani,et al. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. , 2007, Journal of the National Cancer Institute.
[7] Olufunmilayo I. Olopade,et al. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.
[8] J. Chang-Claude,et al. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Giovanni Parmigiani,et al. Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Douglas F. Easton,et al. Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[11] F. Couch,et al. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers , 2007, Breast Cancer Research and Treatment.
[12] A. Whittemore,et al. BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50 , 2006, Cancer Epidemiology Biomarkers & Prevention.
[13] A. Whittemore,et al. No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of BRCA1 and BRCA2 Mutations Ages <50 Years , 2006, Cancer Epidemiology Biomarkers & Prevention.
[14] J. Chang-Claude,et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). , 2006, Journal of the National Cancer Institute.
[15] F. Couch,et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers , 2005, International journal of cancer.
[16] W. Foulkes,et al. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers , 2005, Breast Cancer Research.
[17] O. Olopade,et al. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers , 2005, Cancer Causes & Control.
[18] A. Whittemore,et al. Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations , 2005, Cancer Epidemiology Biomarkers & Prevention.
[19] J. Lubiński,et al. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland , 2005, Breast Cancer Research and Treatment.
[20] D. Horsman,et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of the National Cancer Institute.
[21] J. Jónasson,et al. BRCA2 mutation carriers, reproductive factors and breast cancer risk , 2003, Breast cancer research : BCR.
[22] F. Couch,et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. , 2002, Journal of the National Cancer Institute.
[23] Sean V Tavtigian,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Kantoff,et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. , 2001, Cancer research.
[25] O. Olopade,et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2 , 1999, The Lancet.
[26] D J Schaid,et al. Potential misinterpretation of the case-only study to assess gene-environment interaction. , 1999, American journal of epidemiology.
[27] O. Olopade,et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. , 1998, Journal of the National Cancer Institute.
[28] B. Henderson,et al. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? , 1997, Cancer research.
[29] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[30] Jack A. Taylor,et al. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. , 1994, Statistics in medicine.